The global Gene Sequencing for Basic Science and Medical Research market size is predicted to grow from US$ 16650 million in 2025 to US$ 42700 million in 2031; it is expected to grow at a CAGR of 17.0% from 2025 to 2031.

Gene sequencing for basic science and medical research involves the use of sequencing technologies to analyze the genetic material of organisms in order to understand biological functions, disease mechanisms, and potential therapeutic targets. In basic science, it helps unravel the genetic code that underlies organism development, evolution, and cellular processes. In medical research, gene sequencing is essential for identifying genetic factors involved in diseases, understanding disease pathogenesis, and discovering biomarkers for diagnosis and prognosis. It provides a comprehensive approach to studying human genetics, enabling researchers to uncover the genetic basis of complex conditions such as cancer, neurological disorders, and autoimmune diseases, and to develop more effective treatment strategies.

United States market for Gene Sequencing for Basic Science and Medical Research is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Gene Sequencing for Basic Science and Medical Research is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Gene Sequencing for Basic Science and Medical Research is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Gene Sequencing for Basic Science and Medical Research players cover Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI, Natera, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Gene Sequencing for Basic Science and Medical Research Industry Forecast” looks at past sales and reviews total world Gene Sequencing for Basic Science and Medical Research sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Sequencing for Basic Science and Medical Research sales for 2025 through 2031. With Gene Sequencing for Basic Science and Medical Research sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Sequencing for Basic Science and Medical Research industry.

This Insight Report provides a comprehensive analysis of the global Gene Sequencing for Basic Science and Medical Research landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Sequencing for Basic Science and Medical Research portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Sequencing for Basic Science and Medical Research market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Sequencing for Basic Science and Medical Research and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Sequencing for Basic Science and Medical Research.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Sequencing for Basic Science and Medical Research market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Second-generation Sequencing
    Third- and Fourth-generation Sequencing
    First-generation Sequencing

Segmentation by Application:

    Basic Science and
    Medical Research

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Illumina
    Thermo Fisher Scientific
    Eurofins Scientific
    BGI
    Natera
    Berry Genomics
    WuXi AppTec
    Novogene
    LabCorp
    Macrogen
    Pacific Biosciences
    Azenta Life Sciences
    MGI
    Roche